title: Therapeutic potential of FGF21 in cardiorenal syndrome.
authors.affiliation: Institute of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
authors.forename: Fanghua
authors.initials: F
authors.lastname: Li
authors.affiliation: Institute of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
authors.forename: Chengyuan
authors.initials: C
authors.lastname: Tang
authors.affiliation: Institute of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China; Department of Cellular Biology & Anatomy, Medical College of Georgia at Augusta University, Charlie Norwood VA Medical Center, Augusta, GA 30912, United States. Electronic address: zdong@gru.edu.
authors.forename: Zheng
authors.initials: Z
authors.lastname: Dong
mesh_terms: D000893:Anti-Inflammatory Agents / Q000378:metabolism*; D059347:Cardio-Renal Syndrome / Q000188:drug therapy / Q000378:metabolism*; D005346:Fibroblast Growth Factors / Q000378:metabolism*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects
chemical_list: D000893:Anti-Inflammatory Agents; C414620:fibroblast growth factor 21; D005346:Fibroblast Growth Factors
keywords: Cardiorenal syndrome; Dylipidemia; FGF21; Inflammation; Oxidative stress